Skip to content

ORBIMED ADVISORS LLC: DXCM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on DXCM, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 278,000 DXCM shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 278,000 shares
    Change vs previous 13F not available

    0.44% of the 13F portfolio, value $23,988,620.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested